Sarizotan

DRUG3 trials

Sponsors

EMD Serono, Centre for Addiction and Mental Health

Conditions

DyskinesiaNeuroleptic-induced Tardive DyskinesiaParkinson's Disease

Phase 3

Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia

CompletedNCT00105521

EMD SeronoDyskinesia, Parkinson's Disease

Start: 2004-09-30End: 2006-03-31Updated: 2018-04-02

Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia

CompletedNCT00105508

EMD SeronoDyskinesia, Parkinson's Disease

Start: 2004-09-30End: 2006-02-28Updated: 2018-07-26

Unknown Phase

Sarizotan in the Treatment of Neuroleptic-induced Tardive Dyskinesia

TerminatedNCT00310661

Centre for Addiction and Mental HealthNeuroleptic-induced Tardive Dyskinesia

Start: 2004-12-31End: 2008-03-31Updated: 2015-07-23